Trial · NCT03303521
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Sodium Zirconium Cyclosilicate (SZC) | 3 | 96 | 4 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 5 | 99 | 5 |
| other | Diarrhoea | Gastrointestinal disorders | Sodium Zirconium Cyclosilicate (SZC) | 4 | 96 | 5 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 6 | 99 | 6 |
| serious | Bacteraemia | Infections and infestations | Sodium Zirconium Cyclosilicate (SZC) | 0 | 96 | 0 |
| serious | Bacteraemia | Infections and infestations | Placebo | 1 | 99 | 1 |
| serious | Gangrene | Infections and infestations | Sodium Zirconium Cyclosilicate (SZC) | 1 | 96 | 1 |
| serious | Gangrene | Infections and infestations | Placebo | 0 | 99 | 0 |
| serious | Gastroenteritis viral | Infections and infestations | Sodium Zirconium Cyclosilicate (SZC) | 1 | 96 | 1 |
| serious | Gastroenteritis viral | Infections and infestations | Placebo | 0 | 99 | 0 |
| serious | Vascular device infection | Infections and infestations | Sodium Zirconium Cyclosilicate (SZC) | 0 | 96 | 0 |
| serious | Vascular device infection | Infections and infestations | Placebo | 1 | 99 | 1 |
| serious | Fluid overload | Metabolism and nutrition disorders | Sodium Zirconium Cyclosilicate (SZC) | 0 | 96 | 0 |
| serious | Fluid overload | Metabolism and nutrition disorders | Placebo | 2 | 99 | 2 |
| serious | Hyperkalaemia | Metabolism and nutrition disorders | Sodium Zirconium Cyclosilicate (SZC) | 1 | 96 | 1 |
| serious | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 3 | 99 | 3 |
| serious | Angina pectoris | Cardiac disorders | Sodium Zirconium Cyclosilicate (SZC) | 2 | 96 | 3 |
| serious | Angina pectoris | Cardiac disorders | Placebo | 0 | 99 | 0 |
| serious | Cardiac failure congestive | Cardiac disorders | Sodium Zirconium Cyclosilicate (SZC) | 0 | 96 | 0 |
| serious | Cardiac failure congestive | Cardiac disorders | Placebo | 1 | 99 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03303521/events